The benchmark studies below are part of Best Practices, LLC's ongoing research and consulting initiatives. By participating in one of the following surveys, you will receive a free copy of the results in presentation format. All benchmark study results are blinded and aggregated to ensure confidentiality.
You can download free sample findings of previous Internet Benchmarking Exchange studies, and find all previous results archived in the Best Practice Database. For more information, or to initiate your own benchmark study, please contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com.
Current Benchmark Studies 
Survey Topic: Benchmarking Fair Market Value for Thought Leaders in the Healthcare Industry
Objective: With increasing importance of transparency, healthcare leaders must provide a clear line of sight into how they compensate industry thought leaders and physicians. Bio-pharma executives are being pressed to re-assess their current thought leader compensation strategies as new state reporting laws and changes to their organizations’ policies (PhRMA code, ACCME guidelines, etc.) are being enforced. At the same time, access to thought leaders themselves has continued to shrink, whether in academic institutions or elsewhere. Put simply, it has never been more important for healthcare companies to get it right when it comes to thought leader management. This benchmarking study is designed to examine trends in Fair Market Value for thought leaders, capturing critical metrics and insights on thought leader management, compensation levels, and proven practices.
Lead Researcher: Cameron Tew
Invited Participants: Vice presidents, executives, directors, managers, and other professionals working within Medical Affairs and thought leader management functions.
Time Commitment: Approximately 15-20 minutes
To Participate in this Survey: Click here
Contact: If you have questions about the survey or require assistance, please contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com.
Survey Topic: Patient Support Excellence: Benchmarking the Structure, Activities & Resource Levels that Ensure Patient-Centric Products and Services
Objective: Facing declining sales from patent losses and payer pressures, the pharmaceutical sector is turning to patient support programs and activities to help drive commercial success. But as organizations move to enhance their patient support initiatives, it’s unclear what kind of structure, resources, and activities will ensure success in the competitive global marketplace.
Study results will identify how patient support programs are currently funded, structured, staffed, and budgeted. The study also examines the effectiveness of different patient support activities and patient advocacy group interactions. Pharmaceutical leaders will be able to use the research results to see how their patient support programs stack up against industry averages and trends.
Lead Researcher: Jeff Zimmer
Invited Participants: This study is open to pharma and biotech leaders who conduct or oversee programs that support patients in the U.S. or other countries and work in roles such as brand teams, patient services, patient marketing, new product planning, and patient advocacy.
Time Commitment: Approximately 15-20 minutes
To Participate in this Survey: Click here
Contact: If you have questions about the survey or require assistance, please contact Jeff Zimmer at (919) 767-9180 or jzimmer@best-in-class.com
Survey Topic: Healthcare Digital Marketing Excellence: Driving Better Performance through New Approaches to Customer Engagement
Objective: As technology evolves, healthcare companies must constantly adapt their Digital Marketing approaches to effectively reach customers. Leading organizations innovate across all available channels, using the full power of Digital tools and technologies to integrate multi-channel strategy and tactics into traditional Marketing and Brand approaches.
This benchmarking survey examines how healthcare organizations use advanced analytics to support inbound and outbound Digital Marketing, promote two-way online community engagement with key customer groups, support mobile optimization, provide customer service and field sales team support, and measure overall Digital performance to grow the organization's bottom line and demonstrate the value of the Digital Marketing function on the whole.
Lead Researcher: James Drake
Benefits of Participation: All participants will receive a full copy of the study findings. To ensure complete confidentiality, survey responses will be blinded and aggregated, with no data linked to any company or individual's name.
Invited Participants: Executives, directors, managers or staff specialists who are knowledgeable about their company's Digital Marketing functions.
Time Commitment: Approximately 20-25 minutes.
To Participate in this Survey: Click here
Contact: If you have questions or want clarification on any topic, please contact James Drake at (212) 288-0761 or jdrake@best-in-class.com.
Survey Topic: Developing Top-Tier Medical Affairs Capabilities
Objective: Research results will provide participating medical affairs and health outcomes leaders with actionable data on the :
• Resource measures for the Medical Affairs function
• Medical Affairs impact measures
• Medical Affairs’ role in launch excellence
• Impact of health outcomes data within the Medical Affairs function
• Management of globalization in Medical Affairs
The research will inform medical affairs leaders about how to adapt to a global healthcare environment and what key impact measures communicate the value of medical affairs most effectively. In addition, the study seeks answers for how medical affairs can support the launch process to maximize a product’s potential and how to leverage outcomes data to develop top-notch thought leader relationships.
Lead Researcher: Ozge Uyanik
Invited Participants: You are invited to participate in an important new survey from Best Practices, LLC designed to help biopharmaceutical and medical device leaders probe current trends in medical affairs impact measures, launch excellence and utilization of health outcomes data.
Confidentiality: All company data will be aggregated and displayed without any association with company names or individuals.
Time Commitment: Approximately 20-25 minutes
Forwarding: If this survey is outside your area of interest or expertise, kindly forward to an appropriate colleague or let me know whom I should be reaching out to.
To Participate in this Survey: Click here
Contact: If you have questions about the survey or require assistance, please contact Contact Ozge Uyanik at 919-767-9274 or ouyanik@best-in-class.com.
Survey Topic: Marketing Orphan Compounds
Objective: Orphan drugs are developed for rare diseases that affect five people or fewer in 10,000. Despite its small patient pool,the R&D advances and regulatory incentives have positively impacted the market for orphan drugs. This has encouraged companies to investigate the revenue potential in these drugs that address unmet medical needs. This study is intended to explore strategy and metrics for developing and marketing of orphan drugs.
Lead Researcher: Cameron Tew
To Participate in this Survey: Click here
Contact: If you have questions about the survey or require assistance, please contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com.
Survey Topic: Marketing and Pharmaceutical Global Launch
Objective: This biopharmaceutical study seeks to identify and share best practices, operating insights and lessons learned from launches of pharmaceutical products. Key focus areas include (1) prioritization of product launch activities, (2) allocation of marketing resources, (3) timing and marketing unit responsibility.
Lead Researcher: Cameron Tew
To Participate in this Survey: Click here
Contact: If you have questions about the survey or require assistance, please contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com.
|